- Corporate Officers - V
- Van Naarden Jacob
Insider Trading History of Van Naarden Jacob
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Van Naarden Jacob since 2017.
This trader's CIK number is 1661254.
At the time of last reporting, Van Naarden Jacob was the EVP & Pres., Lilly Oncology of Eli Lilly & Co. (stock ticker symbol LLY).
Also see all insider trading activities at Eli Lilly & Co.
Note that in the past
Van Naarden Jacob also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Loxo Oncology, Inc. (LOXO) by Van Naarden Jacob
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | LOXO | 0 | $0 | 70,574 | $10,551,341 | 89,574 | $452,032 |
| 2017 | LOXO | 0 | $0 | 15,410 | $1,252,117 | 15,410 | $56,210 |
Yearly summary of insider trading at Eli Lilly & Co (LLY) by Van Naarden Jacob
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | LLY | 1,000 | $647,360 | 0 | $0 | 0 | $0 |
| 2024 | LLY | 0 | $0 | 0 | $0 | 3,618 | $0 |
| 2023 | LLY | 0 | $0 | 0 | $0 | 2,785 | $0 |
| 2022 | LLY | 0 | $0 | 0 | $0 | 5,461 | $0 |
Insider trading activities at 2 companies by Van Naarden Jacob:
1. Loxo Oncology, Inc. (LOXO)
2. Eli Lilly & Co (LLY)
Table 1. Insider trading of Loxo Oncology, Inc. (LOXO) by Van Naarden Jacob
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-12-11 | LOXO | Sale | 4,500 | 137.48 | 618,651 |
| 2018-12-10 | LOXO | Sale | 4,500 | 134.24 | 604,062 |
| 2018-12-11 | LOXO | Option Ex | 11,500 | 8.66 | 99,578 |
| 2018-12-10 | LOXO | Option Ex | 4,500 | 13.67 | 61,515 |
| 2018-11-27 | LOXO | Sale | 4,500 | 144.25 | 649,129 |
| 2018-11-26 | LOXO | Sale | 5,500 | 153.99 | 846,945 |
| 2018-11-27 | LOXO | Option Ex | 4,500 | 8.66 | 38,965 |
| 2018-11-26 | LOXO | Option Ex | 5,500 | 3.65 | 20,064 |
| 2018-10-04 | LOXO | Option Ex | 4,500 | 3.65 | 16,416 |
| 2018-10-03 | LOXO | Sale | 5,500 | 167.29 | 920,100 |
| 2018-10-04 | LOXO | Sale | 4,500 | 162.66 | 731,974 |
| 2018-10-03 | LOXO | Option Ex | 5,500 | 3.65 | 20,064 |
| 2018-09-13 | LOXO | Sale | 4,500 | 166.52 | 749,353 |
| 2018-09-12 | LOXO | Sale | 5,500 | 167.28 | 920,056 |
| 2018-09-13 | LOXO | Option Ex | 4,500 | 3.65 | 16,416 |
| 2018-09-12 | LOXO | Option Ex | 5,500 | 3.65 | 20,064 |
| 2018-08-13 | LOXO | Option Ex | 5,500 | 3.65 | 20,064 |
| 2018-08-14 | LOXO | Option Ex | 4,500 | 3.65 | 16,416 |
| 2018-08-13 | LOXO | Sale | 5,500 | 159.14 | 875,269 |
| 2018-08-14 | LOXO | Sale | 4,500 | 159.90 | 719,531 |
| 2018-07-09 | LOXO | Option Ex | 1,541 | 3.65 | 5,621 |
| 2018-07-10 | LOXO | Option Ex | 1,541 | 3.65 | 5,621 |
| 2018-07-10 | LOXO | Sale | 1,541 | 180.80 | 278,609 |
| 2018-07-09 | LOXO | Sale | 1,541 | 187.95 | 289,632 |
| 2018-06-20 | LOXO | Sale | 1,541 | 179.88 | 277,202 |
| 2018-06-19 | LOXO | Sale | 1,541 | 177.38 | 273,342 |
| 2018-06-20 | LOXO | Option Ex | 13,541 | 3.65 | 49,397 |
| 2018-06-19 | LOXO | Option Ex | 1,541 | 3.65 | 5,621 |
| 2018-05-15 | LOXO | Sale | 1,541 | 136.63 | 210,546 |
| 2018-05-14 | LOXO | Option Ex | 1,541 | 3.65 | 5,621 |
| 2018-05-15 | LOXO | Option Ex | 1,541 | 3.65 | 5,621 |
| 2018-05-14 | LOXO | Sale | 1,541 | 137.47 | 211,847 |
| 2018-04-24 | LOXO | Option Ex | 1,541 | 3.65 | 5,621 |
| 2018-04-25 | LOXO | Option Ex | 1,541 | 3.65 | 5,621 |
| 2018-04-24 | LOXO | Sale | 1,541 | 131.29 | 202,319 |
| 2018-04-25 | LOXO | Sale | 1,541 | 130.29 | 200,775 |
| 2018-03-14 | LOXO | Sale | 1,541 | 131.54 | 202,700 |
| 2018-03-13 | LOXO | Sale | 1,541 | 131.41 | 202,507 |
| 2018-03-14 | LOXO | Option Ex | 1,541 | 3.65 | 5,621 |
| 2018-03-13 | LOXO | Option Ex | 1,541 | 3.65 | 5,621 |
| 2018-02-12 | LOXO | Sale | 1,541 | 93.51 | 144,098 |
| 2018-02-13 | LOXO | Option Ex | 1,541 | 3.65 | 5,621 |
| 2018-02-13 | LOXO | Sale | 1,541 | 97.46 | 150,187 |
| 2018-02-12 | LOXO | Option Ex | 1,541 | 3.65 | 5,621 |
| 2018-01-16 | LOXO | Sale | 1,541 | 88.50 | 136,380 |
| 2018-01-17 | LOXO | Sale | 1,541 | 88.34 | 136,127 |
| 2018-01-16 | LOXO | Option Ex | 1,541 | 3.65 | 5,621 |
| 2018-01-17 | LOXO | Option Ex | 1,541 | 3.65 | 5,621 |
| 2017-12-14 | LOXO | Sale | 1,541 | 83.33 | 128,414 |
| 2017-12-15 | LOXO | Option Ex | 1,541 | 3.65 | 5,621 |
| 2017-12-14 | LOXO | Option Ex | 1,541 | 3.65 | 5,621 |
| 2017-12-15 | LOXO | Sale | 1,541 | 79.93 | 123,175 |
| 2017-11-27 | LOXO | Option Ex | 1,541 | 3.65 | 5,621 |
| 2017-11-28 | LOXO | Option Ex | 1,541 | 3.65 | 5,621 |
| 2017-11-27 | LOXO | Sale | 1,541 | 75.27 | 115,989 |
| 2017-11-28 | LOXO | Sale | 1,541 | 74.27 | 114,456 |
| 2017-10-31 | LOXO | Sale | 1,541 | 86.66 | 133,535 |
| 2017-10-30 | LOXO | Sale | 1,541 | 87.81 | 135,310 |
| 2017-10-31 | LOXO | Option Ex | 1,541 | 3.65 | 5,621 |
| 2017-10-30 | LOXO | Option Ex | 1,541 | 3.65 | 5,621 |
| 2017-09-19 | LOXO | Sale | 1,541 | 88.93 | 137,045 |
| 2017-09-18 | LOXO | Sale | 1,541 | 89.11 | 137,318 |
| 2017-09-19 | LOXO | Option Ex | 1,541 | 3.65 | 5,621 |
| 2017-09-18 | LOXO | Option Ex | 1,541 | 3.65 | 5,621 |
| 2017-08-15 | LOXO | Option Ex | 1,541 | 3.65 | 5,621 |
| 2017-08-14 | LOXO | Sale | 1,541 | 73.81 | 113,741 |
| 2017-08-15 | LOXO | Sale | 1,541 | 73.42 | 113,134 |
| 2017-08-14 | LOXO | Option Ex | 1,541 | 3.65 | 5,621 |
Table 2. Insider trading of Eli Lilly & Co (LLY) by Van Naarden Jacob
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-08-13 | LLY | Buy | 1,000 | 647.36 | 647,360 |
| 2024-02-01 | LLY | Option Ex | 3,618 | .00 | 0 |
| 2023-02-16 | LLY | Option Ex | 2,785 | .00 | 0 |
| 2022-02-16 | LLY | Option Ex | 5,461 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Van Naarden Jacob
(EVP & Pres., Lilly Oncology of Eli Lilly & Co at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.